Essential medicines selection

Isoniazid + pyrazinamide + rifampicin – tablet 50 mg + 150 mg + 75 mg – EMLc

21st Expert Committee on the Selection and Use of Essential Medicines

Drug information:

6 - Anti-infective medicines 6.2 - Antibacterials 6.2.4 - Antituberculosis medicines

Formulation:

Isoniazid + pyrazinamide + rifampicin - Tablet (dispersible): 50 mg + 150 mg + 75 mg
Isoniazid + rifampicin - Tablet (dispersible): 50 mg + 75 mg

Application prepared by:

WHO Global TB Programme

Public comments: